Table 2.
Group | n | At Baseline | After 15 Treatments | 30 d After the 15th Treatment | 6 mo After the Last Treatment |
---|---|---|---|---|---|
Experimental | 24 | 23.3 (10.7) | 10.2 (8.4) | 6.9 (4.8) | 11.3 (11.1) |
Control | 9 | 25.3 (10.7) | 22.2 (11.8) | ||
Crossover | 8 | 25.3 (13.2) | 21.91 (13.6) | 19.9 (13.6) | 20.41 (10.9) |
Numbers inside parentheses indicate the standard deviation.